Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism
Authors:
Open Access
- 25 January 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 92 (3) , 334-339
Abstract
Background: The aim of this study was to compare the outcome after simultaneous hepatectomy and splenectomy with that after hepatectomy alone for hepatocellular carcinoma with associated hypersplenism. Methods: Two hundred and four patients with hepatocellular carcinoma and cirrhotic hypersplenism were divided non-randomly into two groups. Ninety-four underwent simultaneous hepatectomy and splenectomy and 110 underwent hepatectomy alone. White blood cell (WBC) and platelet counts, total serum bilirubin levels, immune function, incidence of complications and 5-year survival rates in the two groups were compared. Results: WBC and platelet counts, distribution of T cell subsets, and levels of bilirubin, interferon γ and interleukin 2 were different between the two groups after operation. All patients who underwent hepatectomy and splenectomy but only 15·5 per cent of those who had hepatectomy alone completed adjuvant chemotherapy. The 5-year tumour-free survival rate was significantly higher after hepatectomy and splenectomy than after hepatectomy alone (37 versus 27·3 per cent; P = 0·003), although overall survival rates were similar. Conclusion: Simultaneous hepatectomy and splenectomy was associated with improved 5-year tumour-free survival in patients with hepatocellular carcinoma and hypersplenism.Keywords
Funding Information
- Clinical Key Projects of the Ministry of Health China (321)
This publication has 17 references indexed in Scilit:
- Clinical research of lung cancer in ChinaThe Chinese-German Journal of Clinical Oncology, 2002
- Th1 and Th2 cytokines in a patient with Evans' syndrome and profound lymphopeniaBritish Journal of Haematology, 2000
- Splenectomy in patients with hepatocellular carcinoma and hypersplenism1Journal of the American College of Surgeons, 2000
- A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenismSurgical Endoscopy, 2000
- Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex.Journal of Experimental Medicine, 1995
- Hepatocellular carcinoma with a solitary adrenal metastasis and poor hepatic functional reserve: Report of a caseSurgery Today, 1994
- Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery systemCancer Chemotherapy and Pharmacology, 1994
- Surgery of small hepatocellular carcinoma. Analysis of 144 casesCancer, 1989
- Regulation of tumor growth by soluble spleen factors: Effect of tumor resectionJournal of Surgical Oncology, 1987
- Splenic embolization to prevent dose limitation of cancer chemotherapyAmerican Journal of Roentgenology, 1983